Last reviewed · How we verify

BPX-01, 1% Topical Gel

BioPharmX, Inc. · Phase 2 active Small molecule

BPX-01, 1% Topical Gel is a Small molecule drug developed by BioPharmX, Inc.. It is currently in Phase 2 development. Also known as: BPX-01 Topical Gel.

At a glance

Generic nameBPX-01, 1% Topical Gel
Also known asBPX-01 Topical Gel
SponsorBioPharmX, Inc.
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about BPX-01, 1% Topical Gel

What is BPX-01, 1% Topical Gel?

BPX-01, 1% Topical Gel is a Small molecule drug developed by BioPharmX, Inc..

Who makes BPX-01, 1% Topical Gel?

BPX-01, 1% Topical Gel is developed by BioPharmX, Inc. (see full BioPharmX, Inc. pipeline at /company/biopharmx-inc).

Is BPX-01, 1% Topical Gel also known as anything else?

BPX-01, 1% Topical Gel is also known as BPX-01 Topical Gel.

What development phase is BPX-01, 1% Topical Gel in?

BPX-01, 1% Topical Gel is in Phase 2.

Related